🇺🇸 FDA
Patent

US 8076100

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

granted A61KA61K2039/5256A61K2039/53

Quick answer

US patent 8076100 (Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/5256, A61K2039/53, A61K39/00, A61K39/12